Metraipolis › archive › dc_4f399438d8ca

Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple… — Europe PMC PMID:41065854

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41065854
DOI
10.1007/s00432-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-09T10:58:30.171Z
SHA-256 of the archived text
5fdb13019bbf0f46b5819b261116fa68bfae2549fc2b136eda78b379e18b6196
Stable URL of this page
https://metraipolis.com/documento/dc_4f399438d8ca

How to cite

Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple… — Europe PMC PMID:41065854 — Europe PMC (en), https://europepmc.org/article/MED/41065854 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f399438d8ca (Metraipolis archive dc_4f399438d8ca, sha256 5fdb13019bbf0f46b5819b261116fa68bfae2549fc2b136eda78b379e18b6196)
BibTeX
@misc{dc4f399438d8ca,
  title = {Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple… — Europe PMC PMID:41065854},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41065854},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f399438d8ca; sha256 5fdb13019bbf0f46b5819b261116fa68bfae2549fc2b136eda78b379e18b6196},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41065854. Agents can read the archived copy with the MCP tool read_document.